The Long Run with Luke Timmerman
1,746 FOLLOWERS
Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina, and resilience, to achieve something meaningful. Biotech's relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great..
The Long Run with Luke Timmerman
1w ago
Najat Khan, chief R&D and chief commercial officer of Recursion, on using technology to improve drug discovery ..read more
The Long Run with Luke Timmerman
1M ago
Robert Blum, CEO of South San Francisco-based Cytokinetics, on building a fully integrated biopharma to treat muscle disorders ..read more
The Long Run with Luke Timmerman
1M ago
Mostafa Ronaghi, co-founder and executive board member of Cellanome, on developing technology to look at live cells and cellular interactions at scale ..read more
The Long Run with Luke Timmerman
2M ago
Ram Aiyar, CEO of Cambridge, Mass.-based Korro Bio, on RNA editing medicines ..read more
The Long Run with Luke Timmerman
2M ago
David Schenkein, general partner at GV, on investing in the future of biotech ..read more
The Long Run with Luke Timmerman
3M ago
Alnylam Pharmaceuticals chief scientific officer Kevin Fitzgerald on the past, present & future of RNA interference medicines ..read more
The Long Run with Luke Timmerman
3M ago
Jonathan Bricker, professor in the cancer prevention program at Fred Hutchinson Cancer Center, on how to quit smoking with help from tech and biotech tools ..read more
The Long Run with Luke Timmerman
4M ago
Leslie Williams, CEO of Boston-based hC Bioscience, on developing transfer RNA therapies ..read more
The Long Run with Luke Timmerman
5M ago
Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia ..read more
The Long Run with Luke Timmerman
5M ago
Chris Garcia, professor at Stanford University and co-founder of several biotech startups, on using protein engineering to advance new treatments for cancer and autoimmune diseases ..read more